WHY ARE DIAZEPAM METABOLISM AND POLYMORPHIC S-MEPHENYTOIN HYDROXYLATION ASSOCIATED WITH EACH OTHER IN WHITE AND KOREAN POPULATIONS BUT NOT IN CHINESE POPULATIONS

被引：40
作者：
BERTILSSON, L [1 ]
KALOW, W [1 ]
机构：
[1] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A1,ONTARIO,CANADA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1993年 / 53卷 / 05期
关键词：
D O I：
10.1038/clpt.1993.77
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：608 / 610
页数：3
相关论文
共 12 条
[1]   POLYMORPHIC HYDROXYLATION OF S-MEPHENYTOIN AND OMEPRAZOLE METABOLISM IN CAUCASIAN AND CHINESE SUBJECTS [J].
ANDERSSON, T ;
REGARDH, CG ;
LOU, YC ;
ZHANG, Y ;
DAHL, ML ;
BERTILSSON, L .
PHARMACOGENETICS, 1992, 2 (01) :25-31
[2]   IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J].
BERTILSSON, L ;
HENTHORN, TK ;
SANZ, E ;
TYBRING, G ;
SAWE, J ;
VILLEN, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :348-355
[3]   PRONOUNCED DIFFERENCES BETWEEN NATIVE CHINESE AND SWEDISH POPULATIONS IN THE POLYMORPHIC HYDROXYLATIONS OF DEBRISOQUIN AND S-MEPHENYTOIN [J].
BERTILSSON, L ;
LOU, YQ ;
DU, YL ;
LIU, Y ;
KUANG, TY ;
LIAO, XM ;
WANG, KY ;
REVIRIEGO, J ;
ISELIUS, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (04) :388-397
[4]   DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION [J].
BROLY, F ;
GAEDIGK, A ;
HEIM, M ;
EICHELBAUM, M ;
MORIKE, K ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1991, 10 (08) :545-558
[5]   ANALYSIS OF THE CYP2D6 GENE IN RELATION TO DEBRISOQUIN AND DESIPRAMINE HYDROXYLATION IN A SWEDISH POPULATION [J].
DAHL, ML ;
JOHANSSON, I ;
PALMERTZ, MP ;
INGELMANSUNDBERG, M ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :12-17
[6]   DIAZEPAM DISPOSITION DETERMINANTS [J].
GREENBLATT, DJ ;
ALLEN, MD ;
HARMATZ, JS ;
SHADER, RI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :301-312
[7]   INTERETHNIC VARIATION OF DRUG-METABOLISM [J].
KALOW, W .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (03) :102-107
[8]  
KALOW W, 1992, PHARMACOGENETICS DRU, P865
[9]   MEPHENYTOIN HYDROXYLATION POLYMORPHISM - CHARACTERIZATION OF THE ENZYMATIC DEFICIENCY IN LIVER-MICROSOMES OF POOR METABOLIZERS PHENOTYPED INVIVO [J].
MEIER, UT ;
DAYER, P ;
MALE, PJ ;
KRONBACH, T ;
MEYER, UA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :488-494
[10]   INCIDENCE OF S-MEPHENYTOIN HYDROXYLATION DEFICIENCY IN A KOREAN POPULATION AND THE INTERPHENOTYPIC DIFFERENCES IN DIAZEPAM PHARMACOKINETICS [J].
SOHN, DR ;
KUSAKA, M ;
ISHIZAKI, T ;
SHIN, SG ;
JANG, IJ ;
SHIN, JG ;
CHIBA, K .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (02) :160-169
12